Concepts (108)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colitis, Ulcerative | 6 | 2013 | 75 | 0.710 |
Why?
|
| Crohn Disease | 3 | 2013 | 110 | 0.500 |
Why?
|
| Pouchitis | 2 | 2013 | 8 | 0.470 |
Why?
|
| Colonic Pouches | 2 | 2012 | 16 | 0.390 |
Why?
|
| Intestinal Fistula | 1 | 2012 | 11 | 0.370 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2012 | 37 | 0.370 |
Why?
|
| Proctocolectomy, Restorative | 3 | 2013 | 19 | 0.280 |
Why?
|
| Colonic Polyps | 2 | 2013 | 25 | 0.180 |
Why?
|
| Sarcopenia | 1 | 2020 | 24 | 0.160 |
Why?
|
| Multiple Organ Failure | 1 | 2020 | 44 | 0.160 |
Why?
|
| Hepatitis, Alcoholic | 1 | 2020 | 77 | 0.150 |
Why?
|
| Colorectal Neoplasms | 2 | 2011 | 277 | 0.140 |
Why?
|
| Anastomosis, Surgical | 2 | 2012 | 116 | 0.110 |
Why?
|
| Colon | 2 | 2012 | 147 | 0.110 |
Why?
|
| Retrospective Studies | 7 | 2020 | 6690 | 0.110 |
Why?
|
| Myocardial Revascularization | 1 | 2014 | 76 | 0.100 |
Why?
|
| Adenoma | 1 | 2013 | 70 | 0.100 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2012 | 15 | 0.100 |
Why?
|
| Follow-Up Studies | 3 | 2014 | 2464 | 0.100 |
Why?
|
| Precancerous Conditions | 1 | 2013 | 71 | 0.100 |
Why?
|
| Vitamin D Deficiency | 1 | 2013 | 43 | 0.100 |
Why?
|
| Flagellin | 1 | 2012 | 14 | 0.090 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2011 | 8 | 0.090 |
Why?
|
| Carcinoma | 1 | 2012 | 124 | 0.090 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 215 | 0.090 |
Why?
|
| Confidence Intervals | 1 | 2012 | 240 | 0.090 |
Why?
|
| Gastrointestinal Agents | 1 | 2011 | 26 | 0.090 |
Why?
|
| Electrocardiography | 1 | 2014 | 554 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 455 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 422 | 0.080 |
Why?
|
| Anastomotic Leak | 1 | 2011 | 35 | 0.080 |
Why?
|
| Gastroenterology | 1 | 2011 | 41 | 0.080 |
Why?
|
| Colonic Neoplasms | 1 | 2012 | 222 | 0.080 |
Why?
|
| Immunoglobulin G | 1 | 2012 | 460 | 0.080 |
Why?
|
| Odds Ratio | 1 | 2012 | 768 | 0.080 |
Why?
|
| Surgical Wound Infection | 1 | 2011 | 115 | 0.080 |
Why?
|
| Vaccines | 1 | 2011 | 98 | 0.080 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2011 | 102 | 0.080 |
Why?
|
| Middle Aged | 7 | 2020 | 17701 | 0.080 |
Why?
|
| Toll-Like Receptors | 1 | 2010 | 431 | 0.070 |
Why?
|
| Adult | 6 | 2020 | 16893 | 0.070 |
Why?
|
| Young Adult | 3 | 2013 | 4711 | 0.070 |
Why?
|
| B-Lymphocytes | 1 | 2010 | 572 | 0.070 |
Why?
|
| Myocardial Infarction | 1 | 2014 | 919 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2011 | 725 | 0.060 |
Why?
|
| Hospitalization | 1 | 2014 | 1364 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 1 | 2011 | 863 | 0.060 |
Why?
|
| Child, Preschool | 1 | 2012 | 1999 | 0.060 |
Why?
|
| Biomarkers | 1 | 2012 | 1410 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2011 | 764 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2013 | 1314 | 0.060 |
Why?
|
| Cohort Studies | 1 | 2012 | 2576 | 0.060 |
Why?
|
| Male | 7 | 2020 | 29988 | 0.060 |
Why?
|
| Female | 7 | 2020 | 33000 | 0.060 |
Why?
|
| Prognosis | 3 | 2014 | 1748 | 0.050 |
Why?
|
| Humans | 11 | 2020 | 63607 | 0.050 |
Why?
|
| Child | 1 | 2012 | 4534 | 0.050 |
Why?
|
| Colonoscopy | 2 | 2013 | 100 | 0.040 |
Why?
|
| Risk Factors | 3 | 2020 | 5364 | 0.040 |
Why?
|
| Adolescent | 1 | 2012 | 6257 | 0.040 |
Why?
|
| Ligands | 2 | 2011 | 416 | 0.040 |
Why?
|
| Length of Stay | 1 | 2020 | 815 | 0.030 |
Why?
|
| Massachusetts | 2 | 2014 | 2075 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2012 | 1536 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 1556 | 0.030 |
Why?
|
| Ileal Diseases | 1 | 2013 | 6 | 0.030 |
Why?
|
| Colonic Diseases | 1 | 2013 | 34 | 0.020 |
Why?
|
| NF-kappa B p52 Subunit | 1 | 2012 | 3 | 0.020 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 2012 | 9 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-rel | 1 | 2012 | 16 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 1648 | 0.020 |
Why?
|
| Substance P | 1 | 2011 | 38 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 2011 | 34 | 0.020 |
Why?
|
| Survival Rate | 1 | 2014 | 853 | 0.020 |
Why?
|
| Ileum | 1 | 2011 | 21 | 0.020 |
Why?
|
| Premedication | 1 | 2011 | 20 | 0.020 |
Why?
|
| Preoperative Period | 1 | 2011 | 71 | 0.020 |
Why?
|
| Infliximab | 1 | 2011 | 50 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 212 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2011 | 127 | 0.020 |
Why?
|
| Anal Canal | 1 | 2011 | 37 | 0.020 |
Why?
|
| Poisson Distribution | 1 | 2010 | 53 | 0.020 |
Why?
|
| HMGB1 Protein | 1 | 2010 | 26 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2011 | 206 | 0.020 |
Why?
|
| Immunocompromised Host | 1 | 2011 | 108 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2013 | 350 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2012 | 392 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 418 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2011 | 410 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2011 | 242 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2014 | 879 | 0.020 |
Why?
|
| Gene Expression | 1 | 2012 | 840 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2010 | 663 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 938 | 0.020 |
Why?
|
| Vaccination | 1 | 2011 | 364 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2010 | 758 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2011 | 1151 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2010 | 624 | 0.020 |
Why?
|
| Logistic Models | 1 | 2011 | 1277 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2010 | 324 | 0.020 |
Why?
|
| Cytokines | 1 | 2010 | 934 | 0.020 |
Why?
|
| Time Factors | 1 | 2014 | 3770 | 0.020 |
Why?
|
| Prevalence | 1 | 2010 | 1384 | 0.020 |
Why?
|
| Aged | 2 | 2013 | 14511 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2010 | 2081 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2011 | 2699 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 5493 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 5705 | 0.010 |
Why?
|